DGAP-Stimmrechtsanteile: RHÖN-KLINIKUM AG

DGAP-PVR: RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

RHÖN-KLINIKUM AG

25.05.2016 14:15

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------------

Notification according to section 26 para. 1 WpHG

Prof. Dr. h.c. Ludwig Georg Braun, Ilona Braun, Martin Lüdicke, B. Braun Holding GmbH & Co. KG, die BraHo Verwaltungsgesellschaft mbH, Ludwig G. Braun GmbH & Co. KG and B. Braun Melsungen Aktiengesellschaft (the aforementioned persons collectively the 'Notifying Persons') have informed RHÖN-KLINIKUM AG on May 20, 2016 that their voting interest in RHÖN- KLINIKUM Aktiengesellschaft has crossed the threshold of 20% on May 19, 2016.

With respect to the objectives pursued with the acquisition of the voting rights, the Notifying Persons have informed us on May 20, 2016, pursuant to Section 27a para 1 sentence 1 and 3 of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG) of the following:

1. The shareholding in RHÖN-KLINIKUM Aktiengesellschaft is assumed as a long-term strategic investment.

2. The Notifying Persons have not completed yet their considerations to obtain further voting rights within the next twelve months.

3. The Notifying Persons continue to aim at a representation on the supervisory board of RHÖN-KLINIKUM Aktiengesellschaft relative to the significance of their shareholding in RHÖN-KLINIKUM Aktiengesellschaft. Beyond that, the Notifying Persons do not intend to influence the composition of the administration, management or supervisory board of RHÖN-KLINIKUM Aktiengesellschaft

4. The Notifying Persons do not intend to change the capital structure of RHÖN-KLINIKUM Aktiengesellschaft, especially with regards to the ratio of internal/outside financing and the dividend policy.

With respect to the origin of the used funds, the Notifying Persons notify according to section 27a para 1 sentence 4 of the German Securities Trading Act that the used funds are partly own funds and predominantly external funds in order to finance the purchase of the voting rights.



Bad Neustadt a.d. Saale, 25 May 2016

The Board of Management

___________________________________________________________________________

Dr. Kai G. Klinger SVP - Investor Relations, Corporate Finance and M&A RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736



25.05.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap.de

--------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Salzburger Leite 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------